IMUNON
Live / Applied — Fourth extension granted (statement of use) (as of 11 Jul 2025)
What this means for you
Not registered yet, but its 20 Sept 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97036154
- Mark type
- Stylized text
- Filed
- 20 Sept 2021
- Published for opposition
- 16 May 2023
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals; chemical, biological, and biochemical preparations for scientific purposes or general industrial manufacturing
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, immunotherapies for the treatment of cancer and infectious diseases; biological preparations for the treatment of cancer and infectious diseases; vaccines; pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for the prevention and treatment of cancer; pharmaceutical and biological preparations for the treatment of immune system related diseases and disorders; therapeutic agents for promotion of cancer immunity, namely, therapeutic pharmaceuticals and vaccines for the treatment and prevention of cancer
- Class 042 — Scientific and technological services: Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; bioinformatics analysis, namely, DNA analysis services for scientific research purposes; Development of pharmaceutical preparations for treating cancer; scientific research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology
Owner
- IMUNON, INC., LAWRENCEVILLE, NJ, US
- Celsion Corporation, Lawrenceville, NJ, US
- Celsion Corporation, Lawrenceville, NJ, US
Prosecution history
- 01 Apr 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jul 2025 — SOU EXTENSION 4 GRANTED
- 11 Jul 2025 — SOU EXTENSION 4 FILED
- 11 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2025 — SOU EXTENSION 3 GRANTED
- 09 Jan 2025 — SOU EXTENSION 3 FILED
- 09 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2024 — SOU EXTENSION 2 GRANTED
- 09 Jul 2024 — SOU EXTENSION 2 FILED
- 09 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 12 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED